Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000893404) titled 'FareShare Medically Tailored Meals Pilot Program for Type 2 Diabetes' ... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000892415) titled 'A First in Human, Randomized, Double-Blind, Placebo-Controlled, Ascend... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000896471) titled 'The Application of Stomal Sponges to Eliminate Leakage (TASSEL)' on Au... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000898459) titled 'Phase 2 Double-blind Placebo-controlled Multicenter Cross-over Study w... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ISRCTN29596999) titled 'Helping people with severe mental illness lower their risk of heart disease... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ISRCTN14888946) titled 'A study to look at using electrical stimulation for leg weakness early afte... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000895482) titled 'A study to evaluate the safety, tolerability, pharmacokinetics and pha... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ISRCTN17097981) titled 'Effectiveness of sign language-based cartoon oral health education for hear... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ISRCTN13835301) titled 'Treatment of complex renal calculi' on Aug. 18. Study Type: Interventional... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (EUCTR2024-000601-32-Outside-EU/EEA) titled 'A 24-month, open-label, prospective, multicenter, inter... Read More